Musalten indications
For use Max Pidek Pharmaceuticals as monotherapy and in combination with clavulanic acid: an infectious-inflammatory diseases caused by susceptible microorganisms, including bronchitis, pneumonia, tonsillitis, pyelonephritis, urethritis, infections of the gastrointestinal tract, gynecological infections, infections of the skin and soft tissue, listeria, leptospirosis, gonorrhea.
For use Max Pidek Pharmaceuticals in combination with metronidazole: chronic gastritis in acute, peptic ulcer and duodenal ulcer in acute, associated with Helicobacter Pylori.
Uses of Musalten in details
Musalten is used to treat certain diseases of the respiratory tract and to relieve cough associated with thickened mucous.
Musalten description
Each retard capsule contains Ambroxol 75 mg.
Each tablet contains Ambroxol 30 mg.
Each 5 mL of syrup contains Ambroxol 15 or 30 mg.
Each mL of syrup (infant drops) contains Ambroxol 6 mg.
Musalten is trans-4-[(2-amino-3,5-dibromo-benzyl)amino] cyclohexanol hydrochloride.
It also contains the following excipients: Retard Capsules: Crospovidone collidon CL, carnauba wax, stearyl alcohol, magnesium stearate.
Tablets: Lactose, maize starch, colloidal silica, magnesium stearate.
Syrup: Purified water, sorbitol liquid, glycerol 85%, woodberry aroma (15 mg only), strawberry aroma (30 mg only), hydroxyethylcellulose, benzoic acid, acesulfame potassium, vanilla aroma.
Infant Drops: Hydroxyethylcellulose, sorbitol solution, glycerol 85%, sodium saccharin, pharma flavors, menthol, benzoic acid, propylene glycol.
Musalten dosage
Sustained-Release Capsule: Adults and Children >12 years: 1 cap once daily after meal with plenty of liquid (sufficient supply of liquid supports the expectorant effect of Musalten).
Musalten SR capsule is not suitable for children <12 years.
Tablet: Adults and Children >12 years: 1 tab thrice daily for the first 2-3 days and then 1 tab twice daily or ½ tab thrice daily. Children 6-12 years: ½ tab 2-3 times a day.
Syrup: Adults and Children >12 years: 10 mL thrice daily during the first 2-3 days, them 10 mL twice daily or 5 mL thrice daily. Children 6-12 years: 5 mL 2-3 times a day; 2-5 years: 2.5 mL 3 times a day; <2 years: 2.5 mL 2 times a day.
DS Syrup: Adults and Children >12 years: 5 mL thrice daily for 2-3 days then 5 mL twice daily for 2.5 mL thrice daily. Children 6-12 years: 2.5 mL 2-3 times a day.
Infant Drops: Children 13-24 months: 1.25 mL twice a day; 7-12 months: 1 mL twice a day; ≤6 months: 0.5 mL twice a day.
Musalten interactions
Amoxicillin may decrease the effectiveness of contraceptives for oral administration.
With the simultaneous use of Max Pidek Pharmaceuticals with bactericidal antibiotics (including aminoglycosides, cephalosporins, cycloserine, vancomycin, rifampicin) appears synergies; with bacteriostatic antibiotic (including macrolides, chloramphenicol, lincosamides, tetracyclines, sulphonamide) - antagonism.
Amoxicillin increases the effects of indirect anticoagulants inhibiting intestinal microflora, reduces the synthesis of vitamin K and prothrombin index.
Amoxicillin reduces the effect of drugs, in the process of metabolism that produce PABA.
Probenecid, diuretics, allopurinol, phenylbutazone, NSAIDs decrease the tubular secretion of amoxicillin, which can be accompanied by an increase in its concentration in blood plasma.
Antacids, glucosamine, laxatives, aminoglycosides, slow down and reduce, and ascorbic acid increases the absorption of amoxicillin.
With the combined use of amoxicillin and clavulanic acid pharmacokinetics of both components unchanged.
Musalten side effects
Allergic reactions: urticaria, erythema, edema Quincke, rhinitis, conjunctivitis, rarely - fever, joint pain, eosinophilia, in rare cases - anaphylactic shock.
Side effects associated with chemotherapy effect: possible development of super-infection (particularly in patients with chronic diseases or low resistance of the organism).
With prolonged use at high doses: dizziness, ataxia, confusion, depression, peripheral neuropathy, seizures.
Mostly when Max Pidek Pharmaceuticals used in combination with metronidazole: nausea, vomiting, anorexia, diarrhea, constipation, epigastric pain, glossitis, stomatitis; rarely - hepatitis, pseudomembranous colitis, allergic reactions (urticaria, angioedema), interstitial nephritis, a violation of hematopoiesis.
Mostly when Max Pidek Pharmaceuticals used in combination with clavulanic acid: cholestatic jaundice, hepatitis, rarely - erythema multiforme, toxic epidermal necrolysis, exfoliative dermatitis.
Musalten contraindications
Hypersensitivity to Musalten or to any other excipients of Musalten.
In case of rare hereditary conditions that may be incompatible with an excipient of Musalten, the use of Musalten is contraindicated.
Active ingredient matches for Musalten:
Ambroxol in Mexico.
Ambroxol hydrochloride in Mexico.
| Unit description / dosage (Manufacturer) | Price, USD |
| Solution; Oral; Ambroxol Hydrochloride 15 mg / 5 ml | |
List of Musalten substitutes (brand and generic names): | |
| Munorm (India) | |
| Munorm Syrup (Flamingo) | $ 0.53 |
| Musalten C | |
| Tablet, Film-Coated; Oral; Ambroxol Hydrochloride 30 mg | |
| Muscarin (India) | |
| Muscarin Ambroxol 15 mg, Terbutaline1.25 mg, Guaiphenesin 50 mg. SYR / 100ml (Sipra) | $ 0.43 |
| 100ml (Sipra) | $ 0.43 |
| MUSCARIN syr 100ml (Sipra) | $ 0.43 |
| Musco (Taiwan) | |
| Musco 30 mg x 1000's | |
| Musco 30 mg x 100 x 10's | |
| Musco 3 mg/1 mL x 1 mL | |
| Musco 3 mg/1 mL x 60 mL | |
| Musco 3 mg/1 mL x 100 mL | |
| Musco 3 mg/1 mL x 120 mL | |
| Musco 3 mg/1 mL x 1 gal | |
| Musocan (Thailand) | |
| Musocan 30 mg x 200's (Sriprasit) | |
| Mussibron (Dominican Republic) | |
| Musvan (Mexico) | |
| Mutech (India) | |
| Mutech Ambroxol hydrochloride 15 mg, Terbutaline sulphate 1.25 mg, Guaiphenesin 50 mg, Menthol2.5 mg/5 mL. SYR / 100ml (Pharma-Tech) | $ 0.46 |
| 100ml (Pharma-Tech) | $ 0.46 |
| MUTECH syr 100ml (Pharma-Tech) | $ 0.46 |
| Muxen (Venezuela) | |
| Muximed (Spain) | |
| Muxol (Chile, Colombia, France, Luxembourg, Peru, Romania, Switzerland, Tunisia) | |
| Dragee; Oral; Bisacodyl 10 mg (Andromaco) | |
| Injectable; Injection; Ambroxol Hydrochloride 15 mg / 2 ml (Andromaco) | |
| Solution; Oral; Ambroxol Hydrochloride 15 mg / 5 ml (Andromaco) | |
| Solution; Oral; Ambroxol Hydrochloride 30 mg / 5 ml (Andromaco) | |
| Tablet; Oral; Ambroxol Hydrochloride 30 mg (Andromaco) | |
| Muxol 30 mg x 30 Tablet (Andromaco) | |
| Muxol Flem Adultos (Colombia) | |
| Muxol Flem Niños (Colombia) | |
| Muxol Flem NiГ±os (Colombia) | |
| Muxol Fort (Tunisia) | |
| Muxol Infantil (Peru) | |
| Mybroxol (Thailand) | |
| Mybroxol 30 mg/5 mL x 60 mL | |
| Myracof (Philippines) | |
| Myracof 30 mg x 100's (Medichem) | |
| Myracof syr 30 mg/5 mL 60 mL x 1's (Medichem) | |
| Myracof Tablet (Philippines) | |
| Myrox (Bangladesh) | |
| 150 mg x 10's (Almet) | $ 0.71 |
| Myrox 150mg TAB / 10 (Almet) | $ 0.71 |
| MYROX 150MG TABLET 1 strip / 10 tablets each (Almet) | $ 0.75 |
| MYROX tab 150 mg x 10's (Almet) | $ 0.71 |
| Myrox 150mg Tablet (Almet) | $ 0.08 |
| Myrox Pediatric (Bangladesh) | |
| Myrox SR (Bangladesh) | |
See 3216 substitutes for Musalten | |
References
- PubChem. "ambroxol". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "ambroxol". http://www.drugbank.ca/drugs/DB06742 (accessed September 17, 2018).
- MeSH. "Expectorants". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Musalten are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Musalten. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
1 consumer reported useful
Was the Musalten drug useful in terms of decreasing the symptom or the disease?According to the reports released by ndrugs.com website users, the below mentioned percentages of users say the drug is useful / not useful to them in decreasing their symptoms/disease. The usefulness of the drug depends on many factors, like severity of the disease, perception of symptom, or disease by the patient, brand name used [matters only to a certain extent], other associated conditions of the patient. If the drug is not effective or useful in your case, you need to meet the doctor to get re-evaluated about your symptoms/disease, and he will prescribe an alternative drug.
| Users | % | ||
|---|---|---|---|
| Useful | 1 | 100.0% | |
Consumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yet3 consumers reported age
| Users | % | ||
|---|---|---|---|
| < 1 | 3 | 100.0% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
